Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 23 | 2025 | 294 | 5.000 |
Why?
|
| Trypanosoma cruzi | 21 | 2025 | 236 | 4.110 |
Why?
|
| Microbiota | 4 | 2024 | 390 | 1.340 |
Why?
|
| Ascariasis | 2 | 2024 | 68 | 1.110 |
Why?
|
| Protozoan Vaccines | 3 | 2024 | 96 | 1.100 |
Why?
|
| Host-Parasite Interactions | 2 | 2024 | 71 | 1.060 |
Why?
|
| Vaccines | 4 | 2024 | 366 | 1.050 |
Why?
|
| Leishmaniasis | 1 | 2024 | 33 | 0.910 |
Why?
|
| RNA, Messenger | 4 | 2024 | 2812 | 0.850 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2020 | 6 | 0.710 |
Why?
|
| Parasites | 1 | 2020 | 34 | 0.690 |
Why?
|
| Immunity, Innate | 2 | 2024 | 375 | 0.680 |
Why?
|
| Rhodnius | 2 | 2017 | 2 | 0.670 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1697 | 0.630 |
Why?
|
| Virulence Factors | 2 | 2023 | 176 | 0.600 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 125 | 0.580 |
Why?
|
| DNA, Protozoan | 2 | 2018 | 31 | 0.580 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 484 | 0.560 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2023 | 190 | 0.560 |
Why?
|
| Plant Leaves | 1 | 2017 | 43 | 0.540 |
Why?
|
| Macrophages | 1 | 2020 | 619 | 0.530 |
Why?
|
| Insect Vectors | 1 | 2017 | 109 | 0.510 |
Why?
|
| Cytokines | 3 | 2018 | 1290 | 0.500 |
Why?
|
| Animals | 25 | 2025 | 34016 | 0.460 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 491 | 0.430 |
Why?
|
| Mice, Inbred BALB C | 8 | 2025 | 1003 | 0.390 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2021 | 48 | 0.390 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 381 | 0.380 |
Why?
|
| Mice | 15 | 2025 | 17570 | 0.310 |
Why?
|
| Antibodies, Protozoan | 2 | 2025 | 76 | 0.280 |
Why?
|
| Antigens, Protozoan | 2 | 2024 | 66 | 0.280 |
Why?
|
| Technology | 2 | 2024 | 64 | 0.270 |
Why?
|
| Arecaceae | 2 | 2017 | 2 | 0.260 |
Why?
|
| Recombinant Proteins | 4 | 2023 | 1390 | 0.250 |
Why?
|
| Metabolome | 2 | 2020 | 293 | 0.250 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 429 | 0.240 |
Why?
|
| Horses | 2 | 2023 | 91 | 0.230 |
Why?
|
| Prebiotics | 1 | 2024 | 23 | 0.230 |
Why?
|
| Ascaris suum | 1 | 2024 | 29 | 0.230 |
Why?
|
| Transfection | 2 | 2024 | 1061 | 0.230 |
Why?
|
| Antibody Formation | 1 | 2025 | 266 | 0.230 |
Why?
|
| Saccharomycetales | 2 | 2021 | 37 | 0.220 |
Why?
|
| Rhodococcus equi | 1 | 2023 | 4 | 0.220 |
Why?
|
| Larva | 1 | 2024 | 246 | 0.220 |
Why?
|
| RNA Caps | 1 | 2024 | 31 | 0.220 |
Why?
|
| Actinomycetales Infections | 1 | 2023 | 12 | 0.220 |
Why?
|
| Horse Diseases | 1 | 2023 | 32 | 0.220 |
Why?
|
| Myocarditis | 2 | 2015 | 130 | 0.220 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 111 | 0.220 |
Why?
|
| Trypanocidal Agents | 1 | 2023 | 29 | 0.220 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 44 | 0.210 |
Why?
|
| Parasite Load | 2 | 2020 | 31 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 90 | 0.210 |
Why?
|
| Tissue Distribution | 1 | 2024 | 382 | 0.210 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 368 | 0.210 |
Why?
|
| Immune System | 1 | 2023 | 90 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4344 | 0.200 |
Why?
|
| Molecular Typing | 3 | 2017 | 34 | 0.200 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 297 | 0.190 |
Why?
|
| Models, Animal | 1 | 2024 | 459 | 0.190 |
Why?
|
| Colombia | 3 | 2017 | 48 | 0.190 |
Why?
|
| Probiotics | 1 | 2024 | 214 | 0.190 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.190 |
Why?
|
| Humans | 20 | 2024 | 124780 | 0.190 |
Why?
|
| Zebrafish | 1 | 2024 | 384 | 0.190 |
Why?
|
| Nasal Sprays | 1 | 2021 | 8 | 0.180 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.180 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 50 | 0.180 |
Why?
|
| Death, Sudden | 1 | 2021 | 45 | 0.180 |
Why?
|
| NADPH Oxidase 2 | 1 | 2020 | 40 | 0.180 |
Why?
|
| Vero Cells | 1 | 2020 | 110 | 0.170 |
Why?
|
| RNA | 1 | 2024 | 570 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 700 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 91 | 0.170 |
Why?
|
| Phylogeny | 3 | 2018 | 696 | 0.170 |
Why?
|
| Myocardium | 3 | 2020 | 997 | 0.170 |
Why?
|
| Gene Expression | 2 | 2021 | 1560 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 220 | 0.160 |
Why?
|
| Heart | 2 | 2021 | 710 | 0.160 |
Why?
|
| Transients and Migrants | 2 | 2016 | 23 | 0.150 |
Why?
|
| Genome, Protozoan | 1 | 2018 | 25 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 1597 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2020 | 736 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2021 | 434 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 394 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2020 | 409 | 0.140 |
Why?
|
| Multigene Family | 1 | 2018 | 298 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 472 | 0.140 |
Why?
|
| Thymocytes | 1 | 2017 | 8 | 0.140 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 10 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3715 | 0.140 |
Why?
|
| Insect Control | 1 | 2017 | 13 | 0.140 |
Why?
|
| Thymus Gland | 1 | 2017 | 101 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 993 | 0.130 |
Why?
|
| Ecosystem | 1 | 2017 | 77 | 0.130 |
Why?
|
| Protein Domains | 3 | 2021 | 237 | 0.130 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2015 | 8 | 0.130 |
Why?
|
| Arginine | 1 | 2018 | 332 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 2746 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 76 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 419 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 158 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 468 | 0.110 |
Why?
|
| Base Sequence | 1 | 2018 | 3090 | 0.110 |
Why?
|
| Genotype | 2 | 2017 | 2557 | 0.110 |
Why?
|
| Trypanosomiasis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Chiroptera | 1 | 2013 | 13 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4366 | 0.110 |
Why?
|
| HIV Infections | 1 | 2024 | 1891 | 0.100 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 1151 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2025 | 533 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1883 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1003 | 0.080 |
Why?
|
| Female | 10 | 2025 | 66592 | 0.070 |
Why?
|
| Bolivia | 2 | 2016 | 15 | 0.060 |
Why?
|
| Lung | 2 | 2024 | 1490 | 0.060 |
Why?
|
| Spain | 2 | 2016 | 59 | 0.060 |
Why?
|
| Endemic Diseases | 2 | 2016 | 56 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 97 | 0.060 |
Why?
|
| Hepatomegaly | 1 | 2023 | 21 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2023 | 51 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 1189 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 70 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 180 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 325 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2022 | 41 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 503 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 120 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 42 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2021 | 10 | 0.050 |
Why?
|
| Feces | 1 | 2024 | 727 | 0.050 |
Why?
|
| Bacteria | 1 | 2024 | 484 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2021 | 57 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2021 | 48 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 777 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 574 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 192 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 100 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 186 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 891 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 759 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2018 | 25 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 889 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 2448 | 0.040 |
Why?
|
| Liver | 1 | 2024 | 1739 | 0.040 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 2 | 0.030 |
Why?
|
| Plasma | 1 | 2018 | 98 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2017 | 125 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 439 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2704 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 230 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 909 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1079 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1018 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2015 | 5 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 34 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 324 | 0.030 |
Why?
|
| Cresols | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3038 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 2014 | 9 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 797 | 0.030 |
Why?
|
| United States | 2 | 2024 | 10898 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 26 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1498 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1284 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 169 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 22 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 187 | 0.030 |
Why?
|
| Ecology | 1 | 2013 | 12 | 0.030 |
Why?
|
| Trypanosoma | 1 | 2013 | 10 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 142 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1707 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 975 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2013 | 225 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3066 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 422 | 0.020 |
Why?
|
| Adult | 3 | 2016 | 29510 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3877 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 1497 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1757 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 4803 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3436 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12368 | 0.010 |
Why?
|
| Male | 2 | 2016 | 61298 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 26812 | 0.010 |
Why?
|